Best health-care companies in Massachusetts

EMD Serono, Inc. discovers and develops biopharmaceutical products. The company focuses on specialized areas, such as neurodegenerative diseases, fertility, and metabolic endocrinology, as well as oncology. It offers GONAL-f RFF Pen, a pre-filled and ready-to-use multi-dose FSH for the treatment of infertility; Ovidrel PreFilled Syringe, a ready-to-inject liquid infertility treatment; Luveris, a recombinant human luteinizing hormone; and Cetrotide, an gonadotropin releasing hormone antagonist. The company also provides Saizen for growth hormone deficiency in children and adults; Serostim for HIV-associated wasting; Zorbtive for short bowel syndrome; and Rebif for the treatment of relapsing remitting multiple sclerosis (MS). In addition, it offers Fertility LifeLines, an educational service that offers customized information and support to individuals at various stages of the patient journey. The company offers its products through distributors. It has strategic alliances with Newron Pharmaceuticals, SpA; ZymoGenetics, Inc.; Pfizer Inc.; Brigham and Women's Hospital; and CuraScript, Inc. EMD Serono, Inc. was formerly known as Serono, Inc. and changed its name to EMD Serono, Inc. in January 2007. The company is based in Rockland, Massachusetts. EMD Serono, Inc. operates as a subsidiary of Merck Serono S.A.

Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.

HMFP is the employed physician group at BIDMC. We employ approximately 1200 Harvard Medical School faculty members and have an exclusive affiliation with BIDMC.

Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing.

Instrumentation Laboratory is develop, manufacture and distribute instruments, related reagents and data management solutions, for hospitals around the world, at the point-of-care and in the laboratory. Their solutions include Hemostasis and Acute Care Diagnostic products and services, all designed with a common goal: to help healthcare providers enhance patient care and efficiency.

Cynosure is a developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems. Their products are used to provide a diverse range of treatment applications such as hair removal, skin rejuvenation and scar reduction, as well as the treatment of vascular lesions.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi's programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world's leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Institute For Healthcare Improvement is a membership organization, not elsewhere classified.

Headquartered in Boston, Commonwealth Care Alliance (CCA) is a not-for-profit, community-based healthcare organization whose mission is to improve the health and well-being of people with significant needs by innovating, coordinating and providing the highest quality, individualized care. CCA is a nationally recognized leader in providing care for high-cost, high needs individuals through a proven model that improves quality and health outcomes while reducing overall costs of care. In Massachusetts, CCA's two health plans serve approximately 33,000 members who are dually eligible for Medicaid and Medicare, and for three consecutive years, CCA's One Care plan earned a top rating from a consumer survey conducted by the Centers for Medicare & Medicaid Services.

Organogenesis Inc. is a leading regenerative medicine company with the unique skill set to take complex, living therapies from research and development (R&D), through manufacturing, to successful commercialization to reach patients today. As a pioneer in the field of regenerative medicine, Organogenesis received the first FDA approval of a living, allogeneic, cell based product (Apligraf , approved for the treatment of venous leg ulcers). Apligraf is now the leading regenerative medicine product in the world, with two FDA-approved indications. In 2012 we received an FDA approval for GINTUIT™, a living, human cell-based product that represents a new therapeutic class in dentistry.

Cooley Dickinson Hospital is a nonprofit community hospital located in Northampton, Massachusetts.

Medical Information Technology, Incorporated, is a privately held Massachusetts-based software and service company that develops and sells information systems for health care organizations.

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA. The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.

Atrius Health provides primary and specialty care to more than 745,000 adult and pediatric patients at 31 medical practice locations in eastern Massachusetts. Find a doctor today.

The Lahey Hospital & Medical Center, formerly known as the Lahey Clinic, is a physician-led nonprofit teaching hospital of Tufts University School of Medicine based in Burlington, Massachusetts. The hospital was founded in Boston in 1923 by surgeon Frank H. Lahey, M.D., and is managed by Beth Israel Lahey Health.

Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. They are recognized around the world for advanced imaging systems and technology that enable computed tomography, ultrasound, digital mammography and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. Their CT, MRI, digital mammography and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Today, Analogic's subsystems are used in approximately half of the world's CT and MRI scanners. Their market-leading BK Medical and Ultrasonix branded ultrasound systems, used in procedure-driven markets such as urology, surgery and point-of-care, are sold to clinical end users through their direct sales force. For over 40 years they have enabled customers to thrive, improving the health and enhancing the safety of people around the world. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.

Boston Children's Hospital provides pediatric health care services. The hospital provides surgical, radiological examination, and clinical and cancer research services. Additionally, it offers diabetes, endocrinology, gastroenterology, urology, neonatology, orthopedics, and pulmonology healthcare services. The hospital also provides community service programs and postdoctoral training services. Boston Children's Hospital was founded in 1869 and is based in Boston, Massachusetts. Boston Children's Hospital operates as a subsidiary of Children's Medical Center Corporation.

Foundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.

PerkinElmer is a global leader focused on improving the health and safety of people and the environment. Their dedicated team of 8,000 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues in human and environmental health. Their innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain greater insights into their science to better protect their environment, their food supply and the health of their families.

To patient and clinician safety and to providing high-quality products with the performance and precision clinicians expect. Clinicians and healthcare facilities around the world rely on their products when performing a broad range of ophthalmic and microsurgical procedures.

Heart Technologies is locally owned, with offices in East Peoria, Decatur and Springfield, Heart Technologies, Inc. customizes solutions in telephony, security and networking, specializing in education and major medical industries. Let Heart Technologies, Inc. work with you on your short-term and long-term technology goals and strategies.

Baystate Health is a not-for-profit, integrated health care system serving over 800,000 people throughout western New England.

Smiths Medical ASD, Inc. manufactures and markets medical devices for the hospital, emergency, home, and specialist environments. The company was incorporated in 1985 and is based in Weston, Massachusetts. Smiths Medical ASD, Inc. operates as a subsidiary of Smiths Group plc.

Fairview Hospital is primarily engaged in providing general medical and surgical services and other hospital services.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status-an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University's new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients-near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

American Well is a privately held telemedicine company based in Boston, Massachusetts that connects patients instantly with doctors over secure video. The company provides immediate urgent care web visits for patients in 50 states.

Philips Healthcare provides healthcare solutions for diagnostic, treatment, and preventive care. The company's product portfolio includes CT scanners, ECG equipment, mammography equipment, monitoring equipment, MRI scanners, radiography equipment, resuscitation equipment, ultrasound equipment, molecular imaging devices, X-ray equipment, and more. Philips Healthcare has focused their research and development efforts to develop new approaches in the areas of radiology, cardiology, oncology, decision support, home health, respiratory and other critical areas. Philips Healthcare is a division of Philips, a Dutch diversified technology company that offers consumer electronics and electrical products. The mother company was established in 1891 by Gerard Philips and his father Frederik Philips.

Tecomet is a contract manufacturing, engineering and metal fabrication technology company based in Wilmington, Massachusetts. The Company specializes in net shape forging, precision machining, photochemical etching, surface texturing, vacuum brazing, laser and electron beam welding, and rapid prototyping. Tecomet is ISO13485, ISO9001, and AS9100 certified and has over 45 years of experience supplying precision engineered components and assemblies to the medical, aerospace/defense, and commercial/industrial markets, with special emphasis on orthopedic, trauma, and spinal implants.

Alere Inc., formerly Inverness Medical Innovations, Inc., provides diagnostics and health management solutions. The Company's products and services are focused on infectious disease, cardiology, oncology, drugs of abuse and women's health. Its brands range from over-the-counter tests to lab-based diagnostics to integrated home monitoring solutions. The Company's brands include Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, BinaxNOW, Cholestech LDX, Clearview iFOB Complete, Determine HBsAg, DoubleCheckGold and ImmunoComb. The Company has operations in North America, Europe and Middle East, Asia Pacific, and Latin America and Africa.

INPATIENT SERVICES - PATIENTS RECEIVE TREATMENT FOR THEIR ADDICTION AND/OR MENTAL HEALTH ISSUES IN A PEACEFUL SETTING.

Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes primarily in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. The OmniPod System consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.

Reliant Medical Group provides healthcare services. We offer a unique collaborative approach to care that helps patients through sickness and health with compassion and a dedication to service. We accept all major forms of health insurance.

NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. Its primary product includes the NxStage System One (the System One). NxStage operates in two segments: System One and In-Center. The Company markets the System One to hospitals for treatment of acute kidney failure and fluid overload. In addition to the System One, NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD). These products, which consist of Medisystems, include hemodialysis blood tubing sets, A.V. fistula needles and apheresis needles. The Company's blood tubing set products include the ReadySet High Performance Blood Tubing set (ReadySet), and the Streamline Airless Blood Tubing set (Streamline).

Best Doctors provides an innovative employee health benefit that is improving the quality and cost of healthcare. When faced with important medical decisions, Best Doctors members have access to world-class medical expertise, so they can be absolutely sure they have the right diagnosis and the right treatment.

Saint Vincent Hospital is a 381-bed hospital located in Worcester, Massachusetts.

For 30 years AHP has worked passionately to improve health systems and business operations through research and evaluation, training and technical assistance, and professionally consulting to help organizations and individuals reach their full potential.

SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face.

A teaching hospital of Harvard Medical School, Beth Israel Deaconess Medical Center is renowned for excellence in patient care, biomedical research, teaching and community service. Located in the heart of Boston's medical community, it hosts nearly three quarters of a million patient visits annually in and around Boston.

Five Star Quality Care, Inc., a national healthcare and senior living provider, offers the highest quality of care and service. Five Star has two major operating divisions: Five Star Senior Living and Five Star Rehabilitation Services. The Five Star Senior Living division includes more than 260 Independent Living and Assisted Living facilities, Skilled Health Care facilities, and Continuing Care Retirement Communities. Five Star also offers outpatient health rehabilitation clinics at many of its facilities. Five Star is headquartered in Newton, Massachusetts.

HeartWare International, Inc. develops and manufactures small implantable heart pumps or ventricular assist devices for the treatment of advanced heart failure. The company offers HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. It is also developing the Miniaturized Ventricular Assist Device, a miniaturized device intended for chronic heart failure patients. HeartWare International, Inc. sells and markets its products through clinical studies in the United States, as well as directly to cardiac centers and hospitals internationally. The company is headquartered in Framingham, Massachusetts.

Dana-Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts.

A World Leader in Critical Care and Point of Care Testing, Biotechnology Cell Culture and Fermentation Testing.

Brigham and Women's Hospital is the second largest teaching hospital of Harvard Medical School and the largest hospital of the Longwood Medical and Academic Area in Boston, Massachusetts.

The Center provides an array of innovative services for persons with mental health conditions, substance use conditions and/or developmental disabilities.

Apellis Pharmaceuticals, Inc. is an early stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (COPD). Apellis emerged from a successful transaction between Potentia Pharmaceuticals, Inc. and Alcon Research, Ltd in October 2009 in which Alcon licensed the ocular applications of Potentia's family of complement inhibitors. Apellis holds the worldwide exclusive rights to the extra-ocular uses of these compounds. In May 2010, with start-up capital raised from private investors, Apellis commenced full-scale operations.

Tango Therapeutics delivers the next generation of precision medicine to people with cancer that leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.

Tufts Medical Center is an academic medical center that provides routine and emergency care, research and development, and medical training services. Tufts Medical Center is a 415-bed academic medical center, treating complex diseases and injuries affecting adults and children throughout New England. Its full-service children's hospital, Floating Hospital for Children, offers advanced pediatric care to children of all ages, from babies born significantly before their due dates to maturing adolescents. It also performs heart, kidney, and bone marrow transplants; provides comprehensive neurological and neurosurgical care; and offers cutting-edge cancer treatments. Tufts Medical Center's research program includes bench research, clinical trials, and developments in health policy. Its activities are funded by the National Institutes of Health (NIH), private foundations, and industry and private individuals. Tufts Medical Center consistently ranks among the top 15 percent of the nation's independent hospitals to...

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.

JanusBio has assembled a world's leading drug development team targeting the inhibitions of toll-like receptor 7/8/9. This team contributed to the identification of toll-like receptor 7/8/9 and an understanding of these receptors in auto-immune diseas...

CleanSlate has treatment programs that are grounded in the latest in science and medicine and delivered by teams of licensed medical professionals. That is one reason why their centers feel like the doctor's offices people go to for primary care: clean; cheerful; professional; and safe.

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeutics' vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.

LeMaitre Vascular, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of medical devices and implants for the treatment of peripheral vascular disease worldwide. Its products include embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters; perfusion catheters that temporarily perfuse blood and other liquids into the vasculature; carotid shunts to temporarily divert blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. The company also offers manual contrast injectors for the injection of contrast media into blood vessels; modeling catheters to apply radial pressure to the inside of an aortic stent graft for sealing; radiopaque tape to improve the precision of vascular and endovascular procedures; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. In addition, it provides valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches that are synthetic and biological patches for use in closing incisions in a blood vessel; vein strippers for single-incision removal of varicose veins; and vessel closure systems to attach blood vessels for dialysis access. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Deciphera was established in 2003 based on a deep scientific understanding of kinase inhibitors and a team dedicated to developing sophisticated approaches to therapeutic targeting of kinases. With business and development operations based in Boston, and dedicated research capabilities in close proximity to the University of Kansas, Deciphera has identified small molecule leads for over 50 kinase targets, and has developed a pipeline of small molecule drug candidates for a range of cancers.

SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ we have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells.

Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The company's products also comprise LabChip 3000 Drug Discovery System, which produces data that minimizes false positives and false negatives, and detects weak inhibitors; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; MultiDose G3, an automated dissolution testing system; and active pharmaceutical ingredient workstation. In addition, it offers contract research and transgenic animal services, drug discovery and development services, product support, and validation services. Caliper Life Sciences sells its products through direct sales force and a network of distributors. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.

Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.

We answer questions that support faster, more accurate decision-making throughout the drug development process.

Operates As A Physicians' Office (100%).

Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and greatly reduce the risk of systemic side effects inherent in current therapeutic approaches. Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.

Element Care provides comprehensive, coordinated healthcare to people 55 and over in our PACE centers and at home.

Athenahealth is a leading provider of internet-based business services for physician practices. The Company's service offerings are based on proprietary web-native practice management and electronic health record (EHR) software, a continuously updated payer knowledge-base, integrated back-office service operations, and live patient communications services.

Charm Sciences is a world leader provider of food safety, water quality and environmental diagnostics. Charm's diagnostics portfolio includes test kits and systems for antibiotics, mycotoxins, pesticides, alkaline phosphatase, pathogens, end product microbial assessment, allergen control, water quality and ATP hygiene. Directly and through its network of distributors, Charm products serve the food, beverage, water, pharmaceutical, medical, personal care, environmental, and industrial markets in more than 100 countries. Customers rely on Charm products for excellence in quality, innovation and customer support. Charm Sciences, Inc is an Equal Opportunity Employer M/F/Disabled/Veterans.

Fulcrum Therapectics to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory diseases, and organ transplants. Pandion's approach has the potential to more effectively induce and sustain response and remission in patients with many autoimmune and inflammatory conditions. They aim to shift the paradigm and create a new generation of drugs with transformative efficacy and improved safety.

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. The company's initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson's disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich's ataxia. Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass.

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

MCMC is a leading national managed care services company headquartered in Quincy, MA with primary processing centers located in Los Angeles, CA; Wilton, CT; Hollywood, FL; Overland Park, KS; Jericho, NY; Canonsburg, PA; Nashville, TN and Houston, TX. ...

WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structures. We and our strategic partners are advancing a portfolio of stereopure drug candidates that target underlying biology across a wide range of human diseases. WaVe maintains R&D facilities in Boston and Japan and was founded by two world-renowned scientific leaders, Gregory Verdine and Takeshi Wada. Dr. Verdine is Erving Professor of Chemistry in the Harvard University Departments of Stem Cell and Regenerative Biology, Chemistry and Chemical Biology, and Molecular and Cellular Biology. Dr. Wada is a professor at Tokyo University of Science, Faculty of Pharmaceutical Sciences and Department of Medicinal and Life Science.

Senior Whole Health, LLC, a health maintenance organization, administers healthcare plans for Medicaid and Medicare eligible seniors in Massachusetts, New York, and Connecticut. Its healthcare package includes in-home support services, physician and hospital care, prescription drugs, and dental services. Senior Whole Health, LLC was founded in 2003 and is based in Cambridge, Massachusetts with additional offices in Cambridge and Raynham.

Harvard Pilgrim is a not-for-profit health services company serving members throughout Connecticut, Maine, Massachusetts and New Hampshire. Their mission is to improve the quality and value of health care for the people and communities they serve.

EBNHC provides accessible, high-quality health care to all who live and work in East Boston, Revere, Winthrop, Chelsea, Everett, and the South End.

Holy Family Hospital, Inc. provides primary care medicine, a range of surgical specialties and subspecialties, inpatient and outpatient psychiatry, emergency medicine, critical care, pediatrics, cardiology, neurology, and ambulatory surgery services. The company s services include behavioral health, cancer care, cardiac and vascular, diabetes, diagnostic imaging, emergency medicine, endocrinology, family medicine, general surgery, geriatrics, infectious diseases, internal medicine, kidney diseases, maternity, neurosciences, oral surgery, orthopedics, pain management, plastic surgery, pulmonary medicine, rehabilitation and physical therapy, sleep medicine, substance abuse, thoracic surgery, travel immunization, urology, vascular surgery, vein center, women's health, and wound care; and ear, nose, and throat services. It serves individuals and their families in the Merrimack Valley and southern New Hampshire. The company was founded in 1950 and is based in Methuen, Massachusetts. Holy Family Hospital, Inc. operates as a subsidiary of Steward Health Care System, LLC.

Rubius Therapeutics is creating RCTs™ as a new class of medicines. Leading applications include programs in cancer, enzyme deficiency diseases and the induction of tolerance to treat autoimmune disease. The company was conceived and launched by Flagship VentureLabs , the innovation foundry where a team of scientific entrepreneurs systematically evolve enterprising ideas based upon previously undiscovered areas of science into real-world inventions and ventures.

PROMETRIKA is a global full-service clinical research organization (CRO) with extensive experience in clinical operations, data management, biostatistics, medical writing, and pharmacovigilance.

Victory Programs believes that all people deserve care. For men and women struggling with addiction, we are recovery; For young mothers and children with nowhere to turn, we are shelter; For people coping with HIV/AIDS, we are su...

American Renal Associates Holdings, Inc., through its subsidiaries, owns and operates kidney dialysis facilities. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. The company was formerly known as C.P. Atlas Holdings, Inc. and changed its name to American Renal Associates Holdings, Inc. in February, 2011. American Renal Associates Holdings, Inc. was incorporated in 1999 and is based in Beverly, Massachusetts.

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases. therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and headquartered in Lexington, Massachusetts.

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. The company's treatment aims to stimulate the immune system to recognize and fight cancer cells. Its goal is to treat cancers with novel combinations utilizing its unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines, and adjuvants. In addition to a broad portfolio, the company has an accomplished team of scientists, novel technology platforms, and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. Agenus was established in 1994 and is headquartered in Lexington, Massachusetts.

Scholar Rock, Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our newly elucidated understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. We believe this approach, acting in the disease microenvironment, avoids the historical challenges associated with inhibiting growth factors for therapeutic effect. We believe our focus on biologically validated growth factors may facilitate a more efficient development path. We are advancing our lead product candidate, SRK-015, a selective first-in-class inhibitor of the activation of the growth factor myostatin in skeletal muscle, into clinical development for the treatment of spinal muscular atrophy, or SMA. We expect to initiate a Phase 1 clinical trial in the second quarter of 2018. Utilizing our proprietary platform, we are also creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including other neuromuscular disorders, cancer, fibrosis and anemia.

We are a locally controlled, not-for-profit acute care community hospital committed to delivery of high quality, compassionate care that exceeds expectation.

Keystone Dental was founded in March 2006, and aspires to build a market leading, global brand recognized within the dental community for its integrity, trust and commitment to improving the standard of care for patients and their quality of life. Since then, they have rapidly grown into a diversely skilled, fast-moving team of professionals committed to providing excellent customer service and producing high-quality products and services.

Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation™ Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat. Founded in 2011 by a proven team of scientists and entrepreneurs with world-renowned expertise in the development of targeted cancer therapies, cancer genomics, and rational drug development, Blueprint Medicines is poised to realize the promise of the cancer data “revolution”: truly personalized therapies that improve outcomes and shift cancer to a manageable condition.

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.

Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients. Over the past 50 years, stem cell transplantation has been used in more than 1M patients worldwide. It is currently the only treatment with the potential to cure some of the most devastating hematologic cancers and autoimmune diseases. Despite the increased use and clinical advancements over the past several decades, stem cell transplant remains a high-risk last-resort therapeutic option due to the toxicity and potential long-term side effects.

Anna Jaques Hospital is an independent, not-for-profit community hospital serving 17 cities and towns in the Merrimack Valley, North Shore and Southern New Hampshire

Health Dialog provides population analytics, interactive decision aids, and healthcare decision programs to over 17 million people around the world. Health Dialog is a wholly owned subsidiary of Bupa, a global health and care company of more than $12 billion in revenues headquartered in London, England.

UMass Memorial Health Care (UMMHC) is the clinical partner of the University of Massachusetts Medical School and is the largest health care system in Central and Western Massachusetts.[1] UMMHC is a not-for-profit health care network providing all levels of primary to quartary health care.

Associates of Cape Cod is a biotechnology firm that offers endotoxin detection reagents and contract testing services.

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI i...

Axcella Health is pioneering revolutionary new medicines with a focus on amino acid homeostasis. The company has discovered more than 2,000 diseases with amino acid imbalances and developed a systems pharmacology approach to restore health at the cellular level. Axcella's proprietary platform is clinically validated across several indication areas, with clinical-stage candidates in muscle, neurodegenerative and liver conditions. Axcella is led by a team with a strong track record of leaving a lasting impact on the therapeutic landscape through the development of novel products.

SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.

Boston Medical Center is a private, not-for-profit, academic medical center that provides its patients with trauma and emergency services. It is dedicated to providing accessible health care services to everyone. It also offers many outreach programs and services such as health screenings, smoking cessation, prevention food pantry, bWell center, and interpreter services. Boston Medical Center is based in Boston, Massachusetts.

Delivering a full range of home health, hospice, palliative and wellness services.

BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases with a platform that harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications.

Berg is a Biopharma company in pursuit of next generation medicine. Berg's comprehensive approach covers everything from drug discovery to patient health outcomes.

From overcoming disabilities to struggling substance abuse, Bridgewell supports those in need through compassionate day programs, outpatient treatment, and much more.

MeYou Health was founded in 2009 with the goal of transforming traditional health and wellness programs into social, digital well-being products that help people live healthier, happier lives. Its well-being platform and interventions achieve impact through sustained engagement and measurable effect. This impact has been demonstrated in the market with 60% member engagement at 12 months (with multiple interactions per week) and academically with three randomized control trials and multiple peer-reviewed publications demonstrating positive outcomes. MeYou Health's “open social” model provides extra power to the interventions, because members can participate with anyone in their social network, regardless of each person's health insurance coverage.

Founded in 2007, ClearView Healthcare Partners is a global strategy consulting firm serving the life sciences sector. The firm combines global industry knowledge and deep scientific expertise across a range of therapeutic areas with an extensive network of external stakeholders to deliver practical and actionable recommendations to our clients' most complex challenges. The firm's projects include cross-functional support at the corporate, franchise, and product levels for pharmaceutical, biotech, medtech, and diagnostics companies worldwide.